Introduction: Studies have been conducted to investigate the association between rs10830963 of MTNR1B and the risk of gestational diabetes mellitus (GDM), but with inconclusive results. We aimed to clarify these controversies, especially with regard to the association in the Chinese population. Material and methods: A systemic literature reference search inclusive to August 12, 2016 yielded 35 articles, from which 11 studies met the inclusion criteria for the final meta-analysis, including 3889 patients with GDM and 6708 controls. Results: We found statistically significant associations between rs10830963 and GDM using odds ratios (ORs) and 95% confidence intervals 
Introduction
Gestational diabetes mellitus (GDM), defined as glucose intolerance of variable degree with onset or first recognition during pregnancy, is among the most common metabolic disorders during pregnancy. The prevalence of GDM, with a rising trend globally, varies by area and ethnic population. During the last decade, the prevalence of GDM among western countries varied from 1-3% to 8-18% [1, 2] . For Asian females, including the
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Chinese Han population, the prevalence of GDM was hypothesised to be higher than in Caucasian females [3] .
Studies have shown that GDM is strongly associated with both maternal and offspring adverse health outcomes, including macrosomia, stillbirths, and neonatal metabolic disturbances. Pregnant women with GDM are more likely to be affected with type 2 diabetes mellitus (T2DM) and develop multiple cancers in the years following pregnancy [4] . With the increasing incidence and severe consequence of GDM, it has become a growing health concern.
GDM, caused by environmental and genetic factors, as well as gene-environment interactions, shares similar pathophysiological features to T2DM, such as glucose intolerance, insulin resistance, and impaired pancreatic β-cell function [5] [6] [7] . Furthermore, several studies have revealed that women with GDM history are more likely to develop T2DM. In addition, women with a family history of T2DM may be more predisposed to develop GDM than those without a GDM history [1, 6] . These studies suggest that susceptible genes are involved in T2DM and probably also contribute to the genetic aetiology of GDM. Melatonin receptor 1B (MTNR1B) gene, as a novel diabetogenic gene, is located on human chromosome 11q21-22 [8] [9] [10] [11] and encodes MTNR1B protein, which belongs to the G protein-coupled receptor family and plays an inhibitory role in insulin secretion [12] . Knockout mice of MTNR1B were found to have significantly decreased fasting glucose levels [13] .
Recently, considerable efforts have been devoted to exploring the relationships between the MTNR1B polymorphisms and GDM. Among them, rs10830963, an intron SNP of MTNR1B, has been studied in depth. Because there is controversy among previous studies over the association between the rs10830963 polymorphism and the incidence of GDM and the lack of sufficient evidence about this variation on GDM, we performed a meta-analysis to explore the association between the rs10830963 polymorphism in the MTNR1B gene and GDM risk around the world, especially in the Chinese Han population.
Material and methods

Literature search strategy
We conducted a systemic search on PubMed, Embase, and China National Knowledge Infrastructure (CNKI) databases up to August 12, 2016 using the following keywords: (1) "Melatonin receptor 1B" or "MTNR1B"; (2) "gestational diabetes mellitus" or "GDM" or "pregnancy diabetes mellitus"; and (3) "polymorphism" or "variant" or "genotype". The literature search was restricted to studies published in English or Chinese. In addition, all references of articles retrieved were hand-searched for additional articles relevant to this topic. For articles by the same author using the same case series, we selected the study with the largest sample size. 
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Eligible studies and data extraction
Eligible studies had to meet the following criteria: (1) original papers containing independent data, (2) all patients met the diagnostic criteria for GDM, (3) papers were case-control studies, (4) investigations evaluated the relationship between rs10830963 and GDM susceptibility, and (5) sufficient available published data for odds ratio (OR) estimation with 95% confidence interval (CI) and P-value. The major reasons for excluding studies were: (1) overlapping data, (2) design other than a case-control study, and (3) no available data reported.
Two reviewers (Lu and Wu) blindly performed data extraction separately for all selected publications. For each of the included articles, we extracted the first author's name, publication year, study population (ethnicity), definition and numbers of cases and controls, mean age of cases and controls, body mass index (BMI), frequency of genotypes, Hardy-Weinberg equilibrium status, and genotyping method. For studies that included subjects of different ethnic groups, we extracted data for each one. Further discussion among all authors resolved any disagreement by consensus on a given extracted item.
Statistical methods
Summary statistics were performed with Review Manager 5.1 software (RevMan 5.1. Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration, 2011). Calculating OR and 95% CI measured the strength of association between polymorphism rs10830963 and GDM risk. The statistical significance of the pooled OR was determined with the Z-test. The pooled ORs and 95% CIs were calculated, respectively, by comparisons between the GDM group and control group using the following genetic models: For evaluating possible heterogeneity across the studies, a statistical test for heterogeneity was performed by a Chi-square-based Q-test. Statistical heterogeneity was assessed by I 2 measurement. A random-effect model was adopted when the effects were assumed to be homogenous (I 2 > 50% and p < 0.05). Otherwise, a fixed-effect model was adopted [14] . Two-sided P value less than 0.05 was considered statistically significant.
Results
Characteristics of included studies
We initially identified 35 eligible references. Among these, we excluded 24 studies because of unmatched search criteria, such as not a case-control study, other loci besides rs10830963, or overlapping publications. Finally, 11 studies with 3889 GDM cases and 6708 controls were included in the meta-analysis, and half of the articles focused on the association in the Chinese population [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Figure 1 shows details of the study selection process.
Association of MTNR1B rs10830963 Polymorphism with GDM
As shown in Figure 2 , the heterogeneities for the overall data are small, and p values were all greater than 0.05 in all comparisons except for the GG genotype (I 2 = 51%, p = 0.02). Moreover, according to the stratified analysis of ethnicity, we found that the heterogeneities in the Chinese population subgroup were all small and that there was no significant heterogeneity for any model comparison. This suggests that ethnicity may be a substantial factor contributing to heterogeneity. According to the heterogeneity for comparisons of each model in the overall analysis, we adopted a random-effect model to analyse the GG genotype comparison model. Other comparisons without heterogeneities were analysed using the fixed-effect model. 
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In general, we observed positive evidence of notable associations between the increased risk of GDM and the variant in multiple genetic models when all the eligible studies were pooled into the meta-analysis. Using the fixed effect model, the pooled OR of the G allele was 1.27 (95% CI = 1.20-1.36, p < 0.00001, Figure 3) , and the corresponding results of the dominant and recessive genetic models were 1.31 (95% CI = 1.20-1.44, p < 0.00001, Figure 4 ) and 1.41 (95% CI = 1.26-1.58, p < 0.00001, Figure 5 ), respectively. Therefore, because of the significant heterogeneity, the association for the GG genotype on GDM was analysed using the random effect model, and the pooled OR value was 1.70 (95% CI = 1.38-2.10, p < 0.00001, Figure 2 ). In addition, the association between heterozygote CG genotype and GDM was statistically significant, with the pooled OR being 1.20 (95% CI = 1.09-1.33, p = 0.0003, Figure 6 ).
According to the stratified overall analysis of ethnicity, the Chinese were associated with GDM susceptibility in all genetic models except for the heterozygote CG genotype comparison. To test and verify these significant associations in the Chinese population, we excluded the participants from the Wang (2011) project [18] , who weighed the most in each meta-analysis. After the exclusion, we reassessed the meta-analyses. The results remained significant with pooled OR of 1.62, 1.25, 1.20, and 1.42 for the homozygote genotype, allele, dominant genetic model, and recessive genetic model comparisons, respectively (Supplementary Figure 1) .
Publication bias
We explored publication bias using funnel plots (Figure 7) . The shapes of the funnel plots did not reveal any evidence of obvious visual asymmetry.
Discussion
It is widely believed that GDM shares similar risk factors with T2DM, and women with a GDM history tend to have an increased risk of T2DM [1, 26] . We conducted a meta-analysis to investigate the potential association between the rs10830963 polymorphism in MTNR1B, a genetic variant of a known T2DM loci, and GDM risk. Our results confirmed significant associations of GDM with the rs10830963 polymorphism in the overall population, and especially in the Chinese population. To the best of our knowledge, this study is the first meta-analysis to assess the relationship between the rs10830963 polymorphism and GDM susceptibility in Chinese people.
Despite accumulating evidence recognising multiple risk factors of GDM, the causes underlying the development and progression of GDM have not been fully elucidated. GDM only affects a small proportion of pregnant women, although pregnancy is characterised by progressive insulin resistance and is prone to abnormal glucose tolerance [27, 28] . Normally, the elevated insulin secretion by pancreatic islet β-cells compensates for elevated insulin resistance, but GDM could develop when a genetic predisposition of pancreatic islet β-cell impairment is unmasked by increased insulin resistance during pregnancy [27, 29] . Several studies using the genome-wide association study (GWAS), a powerful method for the detection of genetic contributions to polygenic diseases, suggest that inherited abnormalities of certain genes related to pancreatic islet β-cell function, including MTNR1B, are probably implicated in the aetiology of GDM [10, 30] .
However, because GWAS has been shown to produce false associations [31] , other types of association studies are a useful tool to identify genetic factors conferring susceptibility to diseases. A few genetic association studies have been conducted in various populations to assess possible associations of GDM with the genetic variation of rs10830963. Because original genetic association studies are generally believed to have shortcomings, such as inadequate statistical power, population stratification, and publication bias, we conducted the current meta-analysis to obtain a more comprehensive and intrinsic result of the relationship between the polymorphism of this loci and GDM risk.
The strength of the present study is the systematic way in which we have summarised results of the 
PRACE ORYGINALNE
eligible studies for the SNP-GDM association. Our results indicate that the rs10830963 polymorphism of MTNR1B is a risk factor for GDM, and we found significant associations in all genetic models including the heterozygote CG genotype comparison. Our conclusion is consistent with former meta-analyses by Liu and Zhang [25, 32] . Regarding the population that mainly contributes to the between-study heterogeneity, we performed stratified analyses by ethnicity to evaluate the heterogeneity between studies. Consistent with the results in the overall population, we observed significant associations for the polymorphism in almost all genetic models in the Chinese population. Our results confirmed the earlier finding of a positive association in several studies, with the exception of the study by Wang et al. [18] . The difference in Wang's study could be accounted for by various degrees of clinical heterogeneity, which are induced by the different severities of GDM, comorbidities, and functional status of patients. It should also be noted that consensus of the diagnostic criteria of the current GDM definition differed in the included studies.
In addition, our results of the overall population differed from the Chinese population, which showed no significant association of heterozygote CG genotype frequency of the rs10830963 polymorphism with GDM risk in the Chinese population. The difference may be due to the relatively small number of participants. Only six studies were included in the Chinese meta-analysis. Therefore, additional studies are warranted to further validate ethnic differences of the effect of this polymorphism on GDM risk.
MTNR1A and MTNR1B, both high-affinity receptors of melatonin, are expressed in α-cells and β-cells of the 
pancreatic islets, respectively [33] . The GWAS method has recently shown that the MTNR1B/MT2 receptor may be involved in the pathogenesis of type 2 diabetes mellitus. MTNR1B down-regulates glucokinase expression and glucose-stimulated insulin secretion. An increased expression of MTNR1B on β-cells leads to impaired insulin secretion. Regarding this evidence, and comparing with MTNR1A, we suggest that aberrant MTNR1B expression is involved in the pathogenesis of GDM. Although rs10830963 SNP is in the intron of the MTNR1B gene, the significant association found for this SNP with GDM suggests that the variation plays a key role in the regulation of MTNR1B expression. Previous studies have shown that the G allele of rs10830963 polymorphism in the MTNR1B exhibits a higher expression of this melatonin receptor on the β-cells as compared with that of the C allele. Further studies are required to confirm this association.
Some limitations of this study should be addressed, to understand the results. First, the small sample size of subgroup analysis may not have enough statistical power, so further studies with a larger sample size of target ethnic groups are required. Second, publication bias is a concern in all meta-analyses. Negative studies are less likely to be published or are underreported in published articles, potentially leading to an overestimation of the association. Finally, the integral outcomes were originated in individually unadjusted ORs, while models should be adjusted by potentially confounding factors, including age, nutritional status, and environmental factors.
Conclusions
This study confirms the association of rs10830963 in MT-NR1B with GDM risk. Our results suggest that the variation might increase the incidence of GDM, especially in the Chinese population. Our study provides important clues on the aetiology of GDM, although further studies focusing on the affected pathway are still required.
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